Another Digital Pharma East (DPE) is on the books, and yes, it’s true: DPE was about a month ago, but what we learned is still worth talking about. Check out what Intouch found most interesting at DPE 2019.
We recently sat down with three Intouch experts – Chastity Spencer, Associate Media Director; Antonio Rivera, Associate Director, Inclusion & Diversity; and Chanel Hemphill, Senior Marketing Strategists – to get their thoughts on what brands need to know about the importance of developing marketing messages that speak to all kinds
Pharma marketing still has a ways to go when it comes to matching itself to our multicultural reality, as we pointed out recently in this piece on diversity and inclusion (and offered some suggestions on how to do it well). Particularly in a country that's increasingly “majority-minority” (Americans age 15
As we edge closer to the end of 2019, we wanted to stop and smell the roses, or in this case, indulge in a Throwback Thursday moment and share some of our favorite blog posts from this year. This list represents Intouch’s thinking on a range of topics, from the
Drug pricing is a hot button issue, including the pricing transparency battle, and it's not going away anytime soon. On July 8, U.S. District Court Judge Amit Mehta ruled that the Department of Health and Human Services had overstepped its authority in requiring pricing disclosures, stating, “That policy very well
Digital Pharma East is just around the corner, and this year’s agenda is jam-packed with valuable content on everything from personalization, to HCP digital targeting, to customer engagement, to business transformation and more. The conference -- held September 17-20 in the heart of Philadelphia -- begins with Digital Future Day
This POV describes Colorado House Bill 19-1131 and how it could affect pharma marketers. The bill requires that any one-to-one communications between pharmaceutical representatives (or anyone communicating on their behalf) and prescribers must include written information about the wholesale cost of a drug, as well as the names of at least three generic equivalents. The law goes into effect on August 2, 2019.
Harmonious collaboration produces the best work from your agencies, but getting everyone to be on the same page can be a challenge. How do you ensure that everyone’s doing their part? How can you work effectively and efficiently when there are multiple players, multiple meetings and – more than likely
On July 8, U.S. District Court Judge Amit Mehta ruled that the Department of Health and Human Services had overstepped its authority in requiring pricing disclosures. What happens next?